WELLINGTON MANAGEMENT GROUP LLP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$150,089,505
+16.2%
1,472,043
+3.6%
0.03%
+7.7%
Q1 2023$129,212,049
+125.6%
1,421,162
-5.8%
0.03%
+136.4%
Q4 2022$57,284,437
+45.0%
1,507,882
-4.1%
0.01%
+37.5%
Q3 2022$39,511,000
-67.6%
1,572,266
-60.8%
0.01%
-68.0%
Q2 2022$121,853,000
-15.4%
4,009,660
-8.8%
0.02%0.0%
Q1 2022$144,030,000
+28.4%
4,396,539
+3.4%
0.02%
+38.9%
Q4 2021$112,150,000
-73.7%
4,252,977
+0.2%
0.02%
-75.3%
Q3 2021$426,917,000
-30.3%
4,243,272
-1.9%
0.07%
-28.4%
Q2 2021$612,325,000
+41.0%
4,326,468
-0.7%
0.10%
+34.2%
Q1 2021$434,271,000
-19.2%
4,355,767
+0.2%
0.08%
-23.2%
Q4 2020$537,219,000
+38.2%
4,345,724
+8.9%
0.10%
+23.8%
Q3 2020$388,681,000
-33.4%
3,989,752
+6.6%
0.08%
-38.5%
Q2 2020$583,780,000
+33.9%
3,741,699
+23.9%
0.13%
+13.0%
Q1 2020$436,039,000
-10.9%
3,020,924
+26.3%
0.12%
+11.7%
Q4 2019$489,134,000
+1083.4%
2,392,674
+364.8%
0.10%
+1044.4%
Q3 2019$41,334,000
-13.2%
514,810
+2.0%
0.01%
-18.2%
Q2 2019$47,607,000504,5790.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders